TR201100151A2 - İbandronate formülasyonu. - Google Patents
İbandronate formülasyonu.Info
- Publication number
- TR201100151A2 TR201100151A2 TR2011/00151A TR201100151A TR201100151A2 TR 201100151 A2 TR201100151 A2 TR 201100151A2 TR 2011/00151 A TR2011/00151 A TR 2011/00151A TR 201100151 A TR201100151 A TR 201100151A TR 201100151 A2 TR201100151 A2 TR 201100151A2
- Authority
- TR
- Turkey
- Prior art keywords
- ibandronate
- formulation
- ibandronate formulation
- prevention
- pharmaceutically acceptable
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
- A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TR2011/00151A TR201100151A2 (tr) | 2011-01-06 | 2011-01-06 | İbandronate formülasyonu. |
| TR2011/10526A TR201110526A2 (tr) | 2011-01-06 | 2011-10-24 | Kemik hastalıklarının tedavisinde kullanılmak üzere suda çözünebilir farmasötik formülasyonlar. |
| TR2011/10525A TR201110525A2 (tr) | 2011-01-06 | 2011-10-24 | Kemik hastalıklarının tedavisinde kullanılmak üzere suda çözünebilir farmasötik bileşimler. |
| TR2011/10524A TR201110524A2 (tr) | 2011-01-06 | 2011-10-24 | Kemik hastalıklarının tedavisinde kullanılmak üzere suda çözünebilir yeni formülasyonlar. |
| PCT/TR2012/000008 WO2012093977A1 (en) | 2011-01-06 | 2012-01-03 | Water soluble pharmaceutical formulations comprising ibandronate and an inorganic salt for use in treatment of bone diseases |
| PCT/TR2012/000007 WO2012093976A1 (en) | 2011-01-06 | 2012-01-06 | A composition comprising ibandronate at least 50 % of a filling agent and a sweetener |
| PCT/TR2012/000006 WO2012093975A1 (en) | 2011-01-06 | 2012-01-06 | Water soluble formulations comprising ibandronate sodium with a water content less than 11 % by weight |
| PCT/TR2012/000010 WO2012093979A1 (en) | 2011-01-06 | 2012-01-06 | Water-soluble dosage forms comprising ibandronate |
| EP12704937.7A EP2661270A1 (en) | 2011-01-06 | 2012-01-06 | Water-soluble dosage forms comprising ibandronate |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TR2011/00151A TR201100151A2 (tr) | 2011-01-06 | 2011-01-06 | İbandronate formülasyonu. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR201100151A2 true TR201100151A2 (tr) | 2012-07-23 |
Family
ID=46457629
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2011/00151A TR201100151A2 (tr) | 2011-01-06 | 2011-01-06 | İbandronate formülasyonu. |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP2661270A1 (xx) |
| TR (1) | TR201100151A2 (xx) |
| WO (1) | WO2012093979A1 (xx) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104922060B (zh) * | 2015-05-23 | 2017-10-20 | 河北仁合益康药业有限公司 | 一种伊班膦酸钠注射液组合物 |
| CN107670103A (zh) * | 2017-09-15 | 2018-02-09 | 天津大学 | 聚乙烯吡络烷酮改性的骨水泥及制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3623397A1 (de) | 1986-07-11 | 1988-01-14 | Boehringer Mannheim Gmbh | Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel |
| US5853759A (en) * | 1996-05-17 | 1998-12-29 | Merck & Co.. Inc. | Effervescent alendronate formulation |
| AU712710B2 (en) * | 1996-05-17 | 1999-11-11 | Merck Sharp & Dohme Corp. | Effervescent bisphosphonate formulation |
| US20060034921A1 (en) * | 2004-01-05 | 2006-02-16 | Katdare Ashok V | Effervescent bisphosphonate formulation |
| US20070087052A1 (en) * | 2005-10-19 | 2007-04-19 | Katdare Ashok V | Effervescent bisphosphonate formulation |
-
2011
- 2011-01-06 TR TR2011/00151A patent/TR201100151A2/xx unknown
-
2012
- 2012-01-06 EP EP12704937.7A patent/EP2661270A1/en not_active Withdrawn
- 2012-01-06 WO PCT/TR2012/000010 patent/WO2012093979A1/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| EP2661270A1 (en) | 2013-11-13 |
| WO2012093979A1 (en) | 2012-07-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1124928T1 (el) | Αναστολεις πυραζολυλο κινοξαλινο κινασης | |
| PH12017501306A1 (en) | Inhibitors of histone demethylases | |
| CY1118813T1 (el) | Φαρμακευτικες συνθεσεις συν-κρυσταλλων τραμαδολης και κοξιμπων | |
| TN2012000465A1 (en) | Derivatives of 1-amino-2-cyclopropylethylboronic acid | |
| EA202092456A2 (ru) | Комбинированная терапия, включающая ингибитор mdm2 и один или более дополнительных фармацевтически активных агентов, для лечения различных видов рака | |
| BR112015010663A8 (pt) | formas de dosagem oral de liberação sustentada, e uso de ruxolitinib ou de sal farmaceuticamente aceitável do mesmo | |
| MX2015017964A (es) | Inhibidores de bromodominio. | |
| MY183534A (en) | Alkylpyrimidine derivatives for the treatment of viral infections and further diseases | |
| IN2014MN00948A (xx) | ||
| TW201129382A (en) | Antibody formulation and therapeutic regimens | |
| HN2012000023A (es) | Compuestos y composiciones para el tratamiento de enfermedades parasitarias | |
| IN2014DN10670A (xx) | ||
| EA201591363A1 (ru) | Аналоги тиадиазола и способы лечения состояний, связанных с дефицитом smn | |
| EA201691695A1 (ru) | Терапевтические композиции, содержащие рилпивирин hcl и тенофовира дизопроксилфумарат | |
| MX2016002580A (es) | Combinacion de un inhibidor de alk y un inhibidor de cdk para el tratamiento de enfermedades celulares proliferativas. | |
| MX2014010537A (es) | Moduladores de receptor x del higado (lxr) para el tratamiento de enfermedades, trastornos y condiciones dermicas. | |
| UY33530A (es) | Composiciones farmacéuticas para el tratamiento de enfermedades respiratorias e inflamatorias | |
| EA201270728A1 (ru) | Пуриновые соединения | |
| TR201004464A2 (tr) | Kemik erimesi için formülasyon. | |
| EA201171414A1 (ru) | Ингибиторы белков семейства iap | |
| CY1116158T1 (el) | Υποκατεστημενα 2-οξο- και 2-θειοξο-διυδροκινολινο-3-καρβοξαμιδια σαν διαμορφωτες kcnq2/3 | |
| MX2013010367A (es) | Composiciones y metodos para la terapia y diagnostico de influenza. | |
| MX2015007945A (es) | Usos y métodos para el tratamiento de enfermedades o afecciones hepáticas. | |
| MX2014012321A (es) | Combinacion de analogos de somatostatina con inhibidores de 11-beta-hidroxilasa. | |
| PH12019501820A1 (en) | Pharmaceutical compositions for combination therapy |